Answers are grounded in this paper and cite their sources.
he rising prevalence of type 2 diabetes will impose an increasing burden of diabetic complications on healthcare systems worldwide. The results of the UK Prospective Diabetes Study (UKPDS), and other studies, confirm the potential of effective glycaemic control to improve and extend the lives of people with type 2 diabetes. However, current management algorithms do not achieve sufficient glycaemic control in most patients to realise these improved clinical outcomes. We need a greater readiness to employ intensification of antidiabetic thera- py earlier and in a manner that supports good compliance if we aim to maintain effective, long-term control of type 2 diabetes.
No takes yet. Share an insight, caveat, or question.
Reasner et al. (2002) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: